Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-stage Small Cell Lung Cancer (LS-SCLC)”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Looking for participantsNCT06943235
What this trial is testing

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 60
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773156
What this trial is testing

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Second Affiliated Hospital of Nanchang University 37
Not applicableLooking for participantsNCT07309211
What this trial is testing

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

Who this might be right for
SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Large-scale testing (Phase 3)Looking for participantsNCT07008716
What this trial is testing

Omitting CTV for Primary Tumor in LS-SCLC

Who this might be right for
SCLC, Limited StageRadiation ExposureRadiotherapy Side Effect+1 more
Sun Yat-sen University 852
Testing effectiveness (Phase 2)Looking for participantsNCT07055581
What this trial is testing

Durvalumab as Consolidation for Patients LS-SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Qian Chu 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381543
What this trial is testing

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Who this might be right for
Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07538258
What this trial is testing

Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Yayi He 27
Not applicableStudy completedNCT07050472
What this trial is testing

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

Who this might be right for
Small-cell Lung Cancer
Anhui Shi, MD 45
Testing effectiveness (Phase 2)Looking for participantsNCT07815223
What this trial is testing

A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLC

Who this might be right for
SCLC, Limited Stage
Yantai Yuhuangding Hospital 20
Testing effectiveness (Phase 2)UnknownNCT02738723
What this trial is testing

SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06773910
What this trial is testing

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Who this might be right for
Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC 250
Large-scale testing (Phase 3)Active Not RecruitingNCT06117774
What this trial is testing

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Small Cell Lung CancerSmall Cell Lung Cancer
Amgen 404
Testing effectiveness (Phase 2)UnknownNCT05483543
What this trial is testing

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 44
Testing effectiveness (Phase 2)UnknownNCT04647357
What this trial is testing

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer, LS-SCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06914050
What this trial is testing

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Who this might be right for
Lung Cancer, Small CellLimited-stage Small Cell Lung Cancer (LS-SCLC)
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Testing effectiveness (Phase 2)UnknownNCT05443646
What this trial is testing

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Who this might be right for
Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Testing effectiveness (Phase 2)Looking for participantsNCT06911606
What this trial is testing

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
SCLC, Limited Stage
Guangdong Provincial People's Hospital 45
Next Page